ABT-450/ritonavir/ombitasvir
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABT-450/ritonavir/ombitasvir, covering 2015-01-06 to 2015-01-06. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of ABT-450/Ritonavir/ABT-267; (ABT-267 Also Known as Ombitasvir) and ABT-333 (Also Known as Dasabuvir) Coadministered With Ribavirin (RBV) in Hepatitis C Virus (HCV) Genotype 1-infected Adults With Compensated Cirrhosis [Phase 3]